title: Comparing ticagrelor versus clopidogrel in patients with a history of cerebrovascular disease: a net clinical harm?
authors.forename: James J
authors.initials: JJ
authors.lastname: DiNicolantonio
authors.forename: Victor L
authors.initials: VL
authors.lastname: Serebruany
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000453:epidemiology; D000077144:Clopidogrel; D006801:Humans; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors; D000077486:Ticagrelor; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine